Literature DB >> 27138330

Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions.

Masahito Nakazaki1, Tadashi Nonaka2,3, Akira Takahashi3, Yasuyuki Yonemasu3, Tatsufumi Nomura2,3, Toshiyuki Onda2,3, Osamu Honda3, Yuji Hashimoto3, Hirofumi Ohnishi4, Masanori Sasaki5, Masahiko Daibo3, Osamu Honmou5.   

Abstract

BACKGROUND: The use of distal filter protection alone is associated with a high risk of ischemic complications when vulnerable carotid stenosis is treated by carotid artery stenting (CAS). Double balloon protection, a combination of distal balloon protection and proximal balloon occlusion, can be utilized. We assessed the outcome and complications of the double balloon protection method for vulnerable carotid stenosis.
METHODS: Among 130 patients who underwent CAS from 2009 to 2014, we enrolled the following patients: those whose target lesion was vulnerable as evaluated by MRI, i.e., a signal ratio of plaque to posterior cervical muscle on T1-weighted images before CAS of ≥1.5, and those who underwent diffusion-weighted imaging (DWI) studies within 48 h after the procedure. Ninety patients were enrolled. We investigated DWI findings of the double balloon protection group compared with those of the simple distal balloon protection and distal filter protection groups.
RESULTS: Sixty-four patients (71 %) underwent double balloon protection, 15 patients (17 %) simple distal balloon protection, and 11 patients (12 %) distal filter protection. Symptomatic embolic complications and new lesions on DWI after CAS were significantly less common in patients undergoing double balloon protection compared to distal balloon protection or distal filter protection (0 % vs. 20 %, 9 %, P < 0.01, and 30 % vs. 67 %, 82 %, P < 0.01, respectively). Logistic regression analysis also identified the odds ratio of double balloon protection for new lesions on DWI after CAS of 0.23 (95 % confidence interval: 0.07-0.70, P < 0.01) compared to simple distal protections.
CONCLUSIONS: In the patients who underwent CAS for vulnerable carotid stenosis, double balloon protection was an independent significant factor associated with a reduction in the risk of new lesions on DWI after the procedure compared to conventional distal protections.

Entities:  

Keywords:  Carotid artery stenting; Carotid stenosis; Diffusion-weighted imaging; Double balloon protection; Vulnerable plaque

Mesh:

Year:  2016        PMID: 27138330     DOI: 10.1007/s00701-016-2816-2

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Retrograde three-dimensional rotational angiography: A novel method for the detection of plaque protrusion during carotid artery stenting under continuous distal balloon protection.

Authors:  Hisayuki Hosoo; Wataro Tsuruta; Yusuke Hamada; Masahiro Katsumata; Daiichiro Ishigami; Eiichi Ishikawa; Yuji Matsumaru; Akira Matsumura
Journal:  Interv Neuroradiol       Date:  2020-01-24       Impact factor: 1.610

2.  Treatment Strategy Based on Plaque Vulnerability and the Treatment Risk Evaluation for Internal Carotid Artery Stenosis.

Authors:  Yoshiro Ito; Wataro Tsuruta; Yasunobu Nakai; Tomoji Takigawa; Aiki Marushima; Tomohiko Masumoto; Yuji Matsumaru; Eiichi Ishikawa; Akira Matsumura
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-03-03       Impact factor: 1.742

3.  Endovascular treatment of asymptomatic free-floating thrombus in the carotid artery bifurcation: a direct aspiration first-pass technique under double balloon protection.

Authors:  Ayumu Yamaoka; Kei Miyata; Satoshi Iihoshi; Nobuhiro Mikuni
Journal:  BMJ Case Rep       Date:  2019-08-15

4.  Gradual Expansion of a Stent to Prevent Periprocedural Complications after Carotid Artery Stenting for Vulnerable Severe Stenotic Lesions with Intraplaque Hemorrhages: A Retrospective Observational Study.

Authors:  Takahisa Mori; Kazuhiro Yoshioka; Yuhei Tanno; Shigen Kasakura
Journal:  Life (Basel)       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.